CSE bulletin 2025-1111

The common shares of LIR Life Sciences Corp., previously listed as Blackbird Critical Metals Corp., have been approved for listing on the Canadian Securities Exchange.

Listing and disclosure documents will be available on the CSE website on the trading date.

LIR Life Sciences is a biotechnology company developing transdermal and sublingual drug delivery technologies for GLP-1-based obesity therapies, with the aim of improving accessibility and patient experience.

Issuer:  LIR Life Sciences

Security type:  common shares

Symbol:  SKNY

Number of securities issued and outstanding:  27,866,957

Number of securities reserved for issuance:  433,103

CSE sector:  life sciences

Consolidation:  one new for 1.5 old

Record date for consolidation:  Oct. 31, 2025

Cusip No.:  50206C 10 0

ISIN:  CA 50206C 10 0 5

Old Cusip No.:  09228M 20 7

Old ISIN:  CA 09228M 20 7 6

Board lot:  500

Trading currency:  Canadian dollar

Trading date:  Nov. 7, 2025

Other exchanges:  not applicable

Fiscal year-end:  April 30

Transfer agent:  Odyssey Trust Company

The exchange is accepting market-maker applications for SKNY.